Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer
Background Muscle-invasive bladder cancer (MIBC) can be cured by radical radiotherapy (RT). We previously found tumour MRE11 expression to be predictive of survival following RT in MIBC, and this was independently validated in a separate institute. Here, we investigated germline MRE11A variants as p...
Main Authors: | Teo, M, Dyrskjøt, L, Nsengimana, J, Buchwald, C, Snowden, H, Morgan, J, Jensen, J, Knowles, M, Taylor, G, Barrett, J, Borre, M, Orntoft, T, Bishop, D, Kiltie, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2014
|
Similar Items
-
MRE11 variants as predictive markers of radiotherapy response in muscle invasive bladder cancer
by: Teo, M, et al.
Published: (2012) -
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.
by: Choudhury, A, et al.
Published: (2010) -
High MRE11 expression in muscle invasive bladder cancer is predictive of improved cause-specific survival following radical radiotherapy compared to surgery
by: Teo, T, et al.
Published: (2010) -
MRE11 as a predictive biomarker of outcome following radiotherapy in bladder cancer
by: Walker, AK, et al.
Published: (2019) -
No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy
by: Walker, A, et al.
Published: (2017)